during the period from january 1981 to december 1983 , two groups of a total of 51 patients ( 31 malignant astrocytomas , 17 glioblastomas , and 3 others ) were treated with radioimmunochemotherapy using nimustine hydrochloride ( acnu ) plus picibanil ( ok-432 ) ( group a ) and radiochemotherapy with acnu only ( group b ) in a randomized controlled study .
C0771987
nimustine hydrochloride
C0028096
acnu